Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume

Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,560,500 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest.

Elite Pharmaceuticals saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 1,560,500 shares, a drop of 22.1% from the previous total of 2,004,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elite Pharmaceuticals: Amneal Pharmaceuticals, Inc. (2.92%), Zai Lab Limited (4.68%), Catalyst Pharmaceuticals, Inc. (5.84%), Iovance Biotherapeutics, Inc. (24.07%), Scholar Rock Holding Co. (16.36%), Twist Bioscience Co. (15.20%), Protagonist Therapeutics, Inc. (5.50%), Janux Therapeutics, Inc. (10.18%), Longboard Pharmaceuticals, Inc. (5.70%), IDEAYA Biosciences, Inc. (11.89%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is October, 31 2024.